Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training

NCT ID: NCT02156245

Last Updated: 2019-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

212 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-16

Study Completion Date

2019-04-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the efficacy of a rehabilitation protocol based on individualized combined eccentric and concentric cycle ergometer training compared to classical concentric cycle training among patients with either coronary artery disease (CAD) or chronic obstructive pulmonary disease (COPD). This study will therefore evaluate the efficacy of combined eccentric/concentric training on physical capacity and overall autonomy, and will analyse the adaptive mechanisms with regard to both adaptation to cardiac and muscular effort and tolerance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research will take place in 3 phases:

PHASE 1 :

30 healthy volunteers will be included to test tolerance to personalized exercise on an eccentric cycle ergometer.

PHASE 2 :

15 patients suffering from coronary artery disease (CAD) and 15 patients suffering from chronic obstructive pulmonary disease (COPD) will be included to test the same protocol.

PHASE 3 :

A total of 169 patients split into 2 parallel groups will be included: a group receiving conventional rehabilitation (group A) and the other group receiving eccentric exercise combined to conventional rehabilitation (group B).

Coronary patients: 93 patients will be included (62 patients in group A and 31 in group B).

COPD patients: 76 patients will be included (38 patients per group).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Readaptation to Effort Coronaropathy Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Conventional" group

Group Type EXPERIMENTAL

conventional rehabilitation program (including concentric cycle ergometer)

Intervention Type OTHER

"Combined" group

Group Type EXPERIMENTAL

cycling included into a conventional rehabilitation program

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conventional rehabilitation program (including concentric cycle ergometer)

Intervention Type OTHER

cycling included into a conventional rehabilitation program

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons who have provided written informed consent

Healthy volunteers:

* Men or women aged between 40 and 75 years.

Patients with CAD:

* Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program.
* Left ventricular ejection fraction on echocardiography (Simpson methode) \> 45 %

Patients with Chronic obstructive pulmonary disease:

* Men or women aged between 40 and 75 years
* Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC \< 0.70 and FEV1 ≤ 60% of predicted value)
* Patient not on oxygen therapy (24h/24)

Exclusion Criteria

* Person without national health insurance cover
* Severe, obstructive cardiopathy
* Severe aortic valve stenosis,
* Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test
* Cardiac intracavitary thrombus,
* Severe pulmonary artery hypertension (PAHT systolic \>70mmHg),
* Recent history of venous thromboembolism (previous 3 months),
* Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test \< 24),
* Heart transplant,
* Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…).
* Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index \< 0.6) or orthopedic (degenerative or inflammatory rheumatism).
* Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de BESANCON

Besançon, , France

Site Status

CHU de DIJON

Dijon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CASILLAS DB 2011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.